Kotov, J. A., Kotov, D. I., Linehan, J. L., Bardwell, V. J., Gearhart, M. D., & Jenkins, M. K. (2019). BCL6 corepressor contributes to Th17 cell formation by inhibiting Th17 fate suppressors. J Exp Med.
Styl ChicagoKotov, Jessica A., Dmitri I. Kotov, Jonathan L. Linehan, Vivian J. Bardwell, Micah D. Gearhart, a Marc K. Jenkins. "BCL6 Corepressor Contributes to Th17 Cell Formation By Inhibiting Th17 Fate Suppressors." J Exp Med 2019.
Citace podle MLAKotov, Jessica A., et al. "BCL6 Corepressor Contributes to Th17 Cell Formation By Inhibiting Th17 Fate Suppressors." J Exp Med 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..